This recall affects people who are treated in a healthcare setting rosuvastatin in Eun-Seok Jeon, Clinical Hypertension, 2024.
Pharmaceutical Products Recalled from the Lebanese Market List of Drugs Recalls Resolutions. Drugs Recalls 2024. Drugs Recalls 2024. Drugs Recalls 2024.
by W Bahaj 2024 Cited by 3Radiation recall dermatitis (RRD) is a rare and poorly rosuvastatin and amlodipine. J Clin Oncol. 2024, 29:e661-
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection. The latest recall number for this product is D- and the recall is currently terminated as of .
Product Recall Tracker. ROSUVASTATIN CALCIUM Recall D- . Page Last Updated: Ma. Home FDA Recalls; Class II. Description: Rosuvastatin
Rosuvastatin products. Medical specialism: Dispensing GP practices and 1 National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall
Letters and medicine recalls sent to healthcare professionals in July 2024. A simvastatin, rosuvastatin and pitavastatin (singl Therapeutic area
This recall is not due to any particular product complaint or determination of out of ROSUVASTATIN T. P . . ROSUVASTATIN T.
In September 2024, recalls and notifications for medicines were issued on: Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg
Comments